These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33346100)

  • 1. Recognition of plausible therapeutic agents to combat COVID-19: An omics data based combined approach.
    Hossain MU; Bhattacharjee A; Emon MTH; Chowdhury ZM; Mosaib MG; Mourin M; Das KC; Keya CA; Salimullah M
    Gene; 2021 Mar; 771():145368. PubMed ID: 33346100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A computational approach to design potential siRNA molecules as a prospective tool for silencing nucleocapsid phosphoprotein and surface glycoprotein gene of SARS-CoV-2.
    Chowdhury UF; Sharif Shohan MU; Hoque KI; Beg MA; Sharif Siam MK; Moni MA
    Genomics; 2021 Jan; 113(1 Pt 1):331-343. PubMed ID: 33321203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal analysis of SARS-CoV-2 spike and RNA-dependent RNA polymerase protein sequences reveals the emergence and geographic distribution of diverse mutations.
    Showers WM; Leach SM; Kechris K; Strong M
    Infect Genet Evol; 2022 Jan; 97():105153. PubMed ID: 34801754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different selection dynamics of S and RdRp between SARS-CoV-2 genomes with and without the dominant mutations.
    Koçhan N; Eskier D; Suner A; Karakülah G; Oktay Y
    Infect Genet Evol; 2021 Jul; 91():104796. PubMed ID: 33667722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA-dependent RNA polymerase of SARS-CoV-2 as a therapeutic target.
    Wang Y; Anirudhan V; Du R; Cui Q; Rong L
    J Med Virol; 2021 Jan; 93(1):300-310. PubMed ID: 32633831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precision therapeutic targets for COVID-19.
    Krumm ZA; Lloyd GM; Francis CP; Nasif LH; Mitchell DA; Golde TE; Giasson BI; Xia Y
    Virol J; 2021 Mar; 18(1):66. PubMed ID: 33781287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new insight into sex-specific non-coding RNAs and networks in response to SARS-CoV-2.
    Askari N; Hadizadeh M; Rashidifar M
    Infect Genet Evol; 2022 Jan; 97():105195. PubMed ID: 34954105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of intercontinents mutation hotspots and conserved domains within SARS-CoV-2 genome.
    Omotoso OE; Olugbami JO; Gbadegesin MA
    Infect Genet Evol; 2021 Dec; 96():105097. PubMed ID: 34606987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351).
    Lee J; Lee J; Kim HJ; Ko M; Jee Y; Kim S
    Microbiol Spectr; 2021 Sep; 9(1):e0047221. PubMed ID: 34378968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering the co-adaptation of codon usage between respiratory coronaviruses and their human host uncovers candidate therapeutics for COVID-19.
    Nambou K; Anakpa M
    Infect Genet Evol; 2020 Nov; 85():104471. PubMed ID: 32707288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 CG enables SARS-CoV-2 mutation and lineage tracking by locations and dates of interest.
    Chen AT; Altschuler K; Zhan SH; Chan YA; Deverman BE
    Elife; 2021 Feb; 10():. PubMed ID: 33620031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid design and development of CRISPR-Cas13a targeting SARS-CoV-2 spike protein.
    Wang L; Zhou J; Wang Q; Wang Y; Kang C
    Theranostics; 2021; 11(2):649-664. PubMed ID: 33391497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza.
    Abbott TR; Dhamdhere G; Liu Y; Lin X; Goudy L; Zeng L; Chemparathy A; Chmura S; Heaton NS; Debs R; Pande T; Endy D; La Russa MF; Lewis DB; Qi LS
    Cell; 2020 May; 181(4):865-876.e12. PubMed ID: 32353252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying Small-Molecule Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase by Establishing a Fluorometric Assay.
    Bai X; Sun H; Wu S; Li Y; Wang L; Hong B
    Front Immunol; 2022; 13():844749. PubMed ID: 35464436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-genome sequencing of SARS-CoV-2 reveals the detection of G614 variant in Pakistan.
    Umair M; Ikram A; Salman M; Khurshid A; Alam M; Badar N; Suleman R; Tahir F; Sharif S; Montgomery J; Whitmer S; Klena J
    PLoS One; 2021; 16(3):e0248371. PubMed ID: 33755704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential RNA-dependent RNA polymerase inhibitors as prospective therapeutics against SARS-CoV-2.
    Pokhrel R; Chapagain P; Siltberg-Liberles J
    J Med Microbiol; 2020 Jun; 69(6):864-873. PubMed ID: 32469301
    [No Abstract]   [Full Text] [Related]  

  • 18. Higher entropy observed in SARS-CoV-2 genomes from the first COVID-19 wave in Pakistan.
    Ghanchi NK; Nasir A; Masood KI; Abidi SH; Mahmood SF; Kanji A; Razzak S; Khan W; Shahid S; Yameen M; Raza A; Ashraf J; Ansar Z; Dharejo MB; Islam N; Hasan Z; Hasan R
    PLoS One; 2021; 16(8):e0256451. PubMed ID: 34464419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of Severe Acute Respiratory Syndrome Coronavirus 2 RNA-Dependent RNA Polymerase Inhibitors Using Computational Approach.
    Dhankhar P; Dalal V; Kumar V
    J Comput Biol; 2021 Dec; 28(12):1228-1247. PubMed ID: 34847746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.
    Kandeel M; Ibrahim A; Fayez M; Al-Nazawi M
    J Med Virol; 2020 Jun; 92(6):660-666. PubMed ID: 32159237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.